OppenheimerFunds’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-117,806
| Closed | -$6.22M | – | 1830 |
|
2018
Q1 | $6.22M | Sell |
117,806
-125
| -0.1% | -$6.6K | 0.01% | 745 |
|
2017
Q4 | $8.02M | Sell |
117,931
-330
| -0.3% | -$22.4K | 0.01% | 761 |
|
2017
Q3 | $9.74M | Sell |
118,261
-5,003
| -4% | -$412K | 0.01% | 743 |
|
2017
Q2 | $11.5M | Sell |
123,264
-28,976
| -19% | -$2.71M | 0.01% | 710 |
|
2017
Q1 | $9.69M | Buy |
152,240
+6,344
| +4% | +$404K | 0.01% | 766 |
|
2016
Q4 | $6.48M | Buy |
+145,896
| New | +$6.48M | 0.01% | 810 |
|
2016
Q2 | – | Sell |
-1,246,660
| Closed | -$23.9M | – | 1737 |
|
2016
Q1 | $23.9M | Buy |
1,246,660
+1,150
| +0.1% | +$22.1K | 0.03% | 506 |
|
2015
Q4 | $43.6M | Sell |
1,245,510
-102,300
| -8% | -$3.58M | 0.06% | 366 |
|
2015
Q3 | $124M | Sell |
1,347,810
-169,580
| -11% | -$15.6M | 0.17% | 155 |
|
2015
Q2 | $133M | Buy |
1,517,390
+20,140
| +1% | +$1.77M | 0.15% | 169 |
|
2015
Q1 | $111M | Sell |
1,497,250
-279,724
| -16% | -$20.8M | 0.12% | 199 |
|
2014
Q4 | $99.5M | Sell |
1,776,974
-410
| -0% | -$23K | 0.11% | 213 |
|
2014
Q3 | $80.6M | Buy |
1,777,384
+580,202
| +48% | +$26.3M | 0.09% | 240 |
|
2014
Q2 | $49.6M | Buy |
1,197,182
+346,580
| +41% | +$14.4M | 0.06% | 352 |
|
2014
Q1 | $58.9M | Buy |
+850,602
| New | +$58.9M | 0.07% | 303 |
|